Company Filing History:
Years Active: 2025
Title: Gerwald Jogl: Innovator in Age-Associated Inflammation Research
Introduction
Gerwald Jogl is a notable inventor based in Pawtucket, RI (US). He has made significant contributions to the field of biomedical research, particularly in the area of age-associated inflammation and disorders. With a total of 2 patents, his work focuses on innovative methods for treating and preventing age-related health issues.
Latest Patents
Gerwald Jogl's latest patents include compositions and methods for treating, preventing, or reversing age-associated inflammation and disorders. One of the disclosed methods involves administering a therapeutically effective amount of at least one LINE 1 (L-1) endonuclease inhibitor to patients in need. This method aims to prevent or reverse various age-associated inflammatory conditions linked to the upregulation of L1 and the activation of an IFN-I response. Another patent outlines similar methods using long interspersed nuclear element 1 (LINE-1, L1) endonuclease inhibitors, either alone or in combination with additional therapeutic agents. The effectiveness of these methods can be measured through biomarkers and a decrease in symptoms.
Career Highlights
Gerwald Jogl is affiliated with Brown University, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential to significantly impact the treatment of age-related disorders.
Collaborations
He collaborates with esteemed colleagues, including John M Sedivy and Alexandra D'ordine, to further advance research in this critical area of health.
Conclusion
Gerwald Jogl's contributions to the field of age-associated inflammation research highlight his innovative spirit and dedication to improving health outcomes. His patents represent a significant step forward in understanding and addressing the challenges of aging.